SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (396)4/19/2003 3:49:41 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 631
 
from the PDLI 10-K, filed about three weeks ago.....

We have also decided to conduct additional preclinical studies with our anti- IL-12 antibody before considering further clinical development. Recent scientific investigations have suggested that the putative role of IL-12 in autoimmune disease may actually be mediated by a structurally related cytokine, IL-23.